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to assess Female Sexual Function Index (FSFI) scores and delay to resume sexual activity
associated with a previous severe maternal morbidity.
Method
This was a multidimensional retrospective cohort study. Women who gave birth at a Brazil-
ian tertiary maternity between 2008 and 2012 were included, with data extraction from the
hospital information system. Those with potentially life-threatening conditions and maternal
near miss episodes (severe maternal morbidity) were considered the exposed group. The
control group was a random sample of women who had had uncomplicated pregnancy.
Female sexual function was evaluated through FSFI questionnaire, and general and repro-
ductive aspects were addressed through specific questions. Statistical analyses were per-
formed using Mann-Whitney and Pearson´s Chi-square for bivariate analyses. Logistic
regression was used to identify variables independently associated with lower FSFI scores.
Results
638 women were included (315 at exposed and 323 at not exposed groups). The majority of
women were under 30 years-old in the control group and between 30 and 46 years-old in
the exposed group (p = 0.003). Women who experienced severe maternal morbidity (SMM)
had statistically significant differences regarding cesarean section (82.4% versus 47.1%
among deliveries without complications, p<0.001), and some previous pathological condi-
tions. FSFI mean scores were similar among groups ranging from 24.39 to 24.42. It took lon-
ger for exposed women to resume sexual activity after index pregnancy (mean 84 days
after SMM and 65 days for control group, p = 0.01). Multiple analyses showed no significant
association of FSFI below cut-off value with any predictor.
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Conclusion
FSFI scores were not different in both groups. However, they were lower than expected.
SMM delayed resumption of sexual activity after delivery, beyond postpartum period. How-
ever, the proportion of women in both groups having sex at 3 months after delivery was simi-
lar. Altered sexual response may be evaluated as one of possible long-term consequences
after SMM episodes. Further studies on the growing population of women surviving severe
maternal conditions might be worth for improvement of care for women.
Introduction
In 2013, the worldwide maternal mortality ratio (MMR) was 209 per 100,000 live births [1].
This is only a small part of the whole problem regarding the women´s health care during preg-
nancy, childbirth and postpartum period. For each woman dying, up to thirty others may expe-
rience severe complications that threaten their lives and/or cause any kind of temporary or
permanent adverse consequences [2]. Women who almost died but survived after a severe
obstetric complication are classified as “maternal near miss” according to the WHO (World
Health Organization). This diagnosis is established through clinical, laboratory and/or man-
agement criteria [3].
Mapping severe maternal morbidity among cases of obstetric complications provides fur-
ther information on prevalence and outcome of these conditions. Currently, SMM (severe
maternal morbidity) and more specifically MNM (maternal near miss) are considered to be
better indicators for maternal health condition than maternal mortality ratio alone [3, 4]. Nev-
ertheless, there are not many studies addressing possible negative impacts of such conditions
on women’s future wellbeing and health [5, 6].
In fact, little is known about long-term consequences on women’s physical or emotional
health after an obstetric complication. Most studies on the subject followed these women no
longer than forty-two days after childbirth. Appropriate understanding of the worsening of
general health state following obstetric complications could improve quality of health care for
this population.
Sexual function could theoretically be used to measure the impact of episodes of severe
maternal morbidity on women´s life. However, there is limited data about the occurrence of
sexual dysfunction comparing women with or without maternal morbidity. The Female Sexual
Function Index (FSFI) is a validated instrument that addresses the subjectivity of sexual
response by splitting sexual components (phases) into six domains [7]. Nevertheless, women
who experienced severe maternal morbidity have not yet been properly studied regarding their
sexual function. Between 60% and 90% of postpartum women are expected to resume sexual
activity up to three months after an uncomplicated pregnancy [8]. Even so, there are not many
studies addressing time to resumption of sexual intercourse after obstetric complications.
Overall, it is not yet clear if severe maternal morbidity and near miss change female sexual
response.
Therefore, the objective of this study was to assess Female Sexual Function Index (FSFI)
scores and delay to resume sexual activity in association with severe maternal morbidity, in a
cohort of women in Brazil.
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Method
Setting and population
We conducted a multidimensional retrospective cohort study among women who gave birth
between 1st of July 2008 and 30th of June 2012 at the maternity of the University of Campinas,
in Brazil. This health facility is a tertiary referral unit in southeast Brazil. Female sexual func-
tion was one of several outcomes evaluated. Further aspects of health related conditions studied
were general and reproductive health, disabilities, quality of life, posttraumatic stress disorder,
substance abuse, and growth and development of children from the index pregnancy [5, 6].
These data are still to be published. These possible repercussions were assessed through vali-
dated questionnaires applied at two groups of women according to the exposure. The exposed
group included women who presented potential life threatening conditions and/or maternal
near miss episodes (both operationally defined as severe maternal morbidity) during preg-
nancy, childbirth and postpartum period, using the recent WHO definition and criteria [3].
The control (not exposed) group was a random sample of women who had had uncomplicated
pregnancy, whose delivery occurred around the same time of each case. Time spent from deliv-
ery until interviews ranged from 6 months up to 5 years.
Sample size estimation
The sample size was originally estimated for the whole cohort, considering all the outcomes to
be evaluated and mainly the results for the disabilities and functioning using the WHO Disabil-
ity Assessment Schedule (WHODAS 2.0) questionnaire. There are very few studies addressing
the influence of severe maternal morbidity and/or maternal near miss on sexual aspects of
women´s lives [9,10]. Specifically for aspects of sexual life, results of a previous cohort were
used for sample size estimation [10]. Using the information of 43.1% of women who experi-
enced maternal near miss referring any problems with sexual relations in comparison with
18.7% among women with uncomplicated pregnancies, a ratio of exposed to not exposed of
1:1, a type I error of 0.05 and type II error of 0.10, a total of 162 women would be necessary in
each group. This is below the number currently evaluated.
Selection of subjects
Fig 1 describes procedures for the search of eligible participants. Through hospital electronic
database, 1,157 women matched the selection criteria, i.e. either had had an episode of SMM or
had delivered at the maternity without complications. All women who could be traced by tele-
phone or mail letters were included and only non-responders were excluded. Using a system
already available for telephone interview, 840 women were traced and contacted, what repre-
sented 72.6% of eligible subjects, and were invited to join the study by telephone. The 803
women who agreed to participate (95.6% of acceptance rate) recorded their agreement to the
consent form read by the interviewer and then, were interviewed at that moment using the
Computer Assisted Telephone Interview (CATI) system [11]. Thus, 384 exposed and 419 not
exposed women answered the questionnaires SF 36 (Quality of Life) and PTSD (Posttraumatic
Stress Disorder). In addition, by the end of telephone conversation, the participating women
were invited to come for a face-to-face visit at the hospital when they should also bring their
children (from the specific pregnancy being assessed) for evaluation. The second interview was
scheduled at women´s convenience with expenses covered. Out of 803 participants that were
initially recruited, 638 came to the second stage, which conferred the continuity rate of 79.5%.
Among those women, 323 were controls, and 315 had experienced severe maternal morbidity,
including 67 maternal near miss cases. The 638 women who answered the FSFI compared with
Sexual Function and Severe Maternal Morbidity
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Fig 1. Flow chart for study inclusion.
doi:10.1371/journal.pone.0143581.g001
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those 165 initially eligible but not coming for the interview showed no significant different
results for maternal age, parity, mode of delivery, sex of the child and neonatal outcome (data
not shown).
Data collection
During hospital interviews, after new written informed consents for the women and their chil-
dren were read and signed, we obtained information about reproductive and general health of
women before and after the index gestation, and applied validated questionnaires for address-
ing all the objectives of the whole study. For general health and reproductive aspects assess-
ment, a specific instrument was developed. Along with obstetric background, questions
covered also time to resume sexual activity after index pregnancy. We applied the Female Sex-
ual Function Index (FSFI) for assessing female sexual response, comparing each six-domain
scores and the total FSFI scores (mean, SD and median) between both groups. At this point,
WHODAS 2.0 questionnaire [12], Denver Developmental Screening Test [13], and the stan-
dard WHO questionnaire ASSIST for drug use [14] were also applied in these women or their
children, plus the measurement of weight and height of children. These results will be further
detailed explored.
Data management and analyses
Finally, collected data were manually transcript on previously printed forms, and later digitally
included in an electronic database built with LimeSurvey1. Further, data were transferred to
SPSS files and, before analysis, detailed multiple processes of checking data consistency were
developed. For each inconsistency found, the original form and/or the correspondent clinical
records were re-checked to correct the database. If this was not enough, the woman was con-
tacted again by telephone to check the information. This process was repeated as many times
as necessary to obtain a clean database with no inconsistencies. Non-parametric Mann-Whit-
ney and Pearson´s or Yates Chi-square tests were used to compare general characteristics of
women, time to resume sexual activity and FSFI mean and median scores in both groups. The
cut-off value for FSFI to be considered low was 26.55 (7). Poisson multiple regression analysis
was performed to identify variables independently associated with lower FSFI scores. The
report was prepared following the recommendations of the STROBE statement [15]. The data-
base is available in S1 File.
Ethical aspects
The study was approved by the Institutional Review Board of the University of Campinas and
was sponsored by the CNPq (Brazilian National Research Council), which played no other role
on the development of the study, data collection, analyses and the report. Women had two
inform consent forms, one for the first step of the study performed by telephone where they
orally gave their consent that was recorded, and the second for the face-to-face interview with
them and their children, which they read and signed.
Results
Table 1 shows sociodemographic, pregnancy and perinatal characteristics of included women.
Age was significantly different in both groups. The majority of women in the control group
were under 30 years-old (52%), and 61% in exposed women were between 30 and 46 years-old.
Cesarean section was more frequently performed among women with severe maternal morbid-
ity (82.5%), compared with women in the control group (47.1%). Women who developed
Sexual Function and Severe Maternal Morbidity
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Table 1. Socio demographic, pregnancy and perinatal characteristics of women according to mater-
nal morbidity. SMM: severe maternal morbidity. Values in bold mean that they are statistically significant
(p<0.05).
Characteristics Group
SMM No SMM p-value*
Maternal age (y) n (%) n (%) 0.003
 19 10 (3.2) 19 (5.9)
20–29 113 (35.9) 149 (46.1)
30–39 146 (46.3) 128 (39.6)
 40 46 (14.6) 27 (8.4)
Number of pregnancies 0.778
1 102 (32.4) 109 (33.7)
2 213 (67.6) 214 (66.3)
Ethnicity 0.086
White 152 (48.3) 133 (41.2)
Non white 163 (51.7) 190 (58.8)
Schooling (years) a 0.295
Up to 8 102 (32.5) 91 (28.3)
Above 8 212 (67.5) 230 (71.7)
Marital status b 0.871
With partner 259 (82.5) 269 (83.3)
No partner 55 (17.5) 54 (16.7)
Time since delivery (y) 0.096
< 1 45 (14.3) 40 (12.4)
1–<2 95 (30.2) 127 (39.3)
2–<3 107 (34.0) 101 (31.3)
 3 68 (21.6) 55 (17.0)
Route of delivery a <0.001
Vaginal 55 (17.6) 171 (52.9)
Cesarean section 257 (82.4) 152 (47.1)
Perinatal outcome c 0.087
Alive 261 (95.3) 309 (98.1)
Neonatal death 13 (4.7) 6 (1.9)
Previous conditions
Chronic hypertension 72 (22.9) 21 (6.5) <0.001
Morbid obesity 65 (20.6) 36 (11.1) 0.002
Diabetes 21 (6.7) 9 (2.8) 0.033
Smoking 18 (5.7) 3 (0.9) 0.002
Cardiac diseases 17 (5.4) 3 (0.9) 0.003
Respiratory diseases 16 (5.1) 4 (1.2) 0.011
Thyroid diseases 21 (6.7) 8 (2.5) 0.019
Neurologic diseases 13 (4.1) 4 (1.2) 0.043
Renal diseases 11 (3.5) 1 (0.3) 0.008
Total 315 323
*Pearson Chi-square test for tables greater than “2x2” and Yates Chi-square test for tables “2x2”.
Missing information for a: 3; b: 1; c: 49 cases.
doi:10.1371/journal.pone.0143581.t001
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severe maternal morbidity had also more prevalent previous pathological conditions, such as
hypertensive disorders (23% versus 6.5%), obesity (21% versus 11%), diabetes (7% versus 3%),
cardiac diseases (5.5% versus 1%), respiratory diseases (5% versus 1%), thyroid dysfunction
(6.7% versus 2.5%), neurologic (4.1% versus 1.2%) and renal diseases (3.5% versus 0.3%).
Smoking was also more common among exposed women (5.7% versus 0.9%). There were no
differences between groups regarding number of pregnancies, ethnicity, years of schooling, or
perinatal outcomes. Having a partner and time of breastfeeding were also similar in both
groups.
The mean and median FSFI scores were similar in the population studied. After either an
episode of severe maternal morbidity (MNM or PLTC) or pregnancies without complication,
total FSFI scores were respectively 24.39 and 24.42. Specific domains of FSFI questionnaire also
showed no differences among groups (Table 2).
Moreover, we found no association between FSFI scores and women´s individual or preg-
nancy characteristics (Table 3). After either severe maternal morbidity or uncomplicated child-
birth, total FSFI scores did not significantly differ at same age or parity, years of schooling,
marital status, ethnicity, route of delivery, or perinatal outcome. Not exposed women under 19
years-old had the highest total FSFI mean score (27.53), while those without a partner had the
lowest total FSFI mean score (19.04), however also not significantly different from those with
Table 2. Mean andmedian values for FSFI total and domain scores according to maternal morbidity. SMM: severe maternal morbidity; PLTC: poten-
tially life threatening condition; MNM: maternal near miss. Values in bold mean that they are statistically significant (p<0.05).
Morbidity Mean SD Median Min Max n p-value *
Desire domain 0.684
SMM 3.33 1.28 3.60 1.2 6.0 315
No morbidity 3.37 1.17 3.60 1.2 6.0 323
Arousal domain a 0.438
SMM 3.40 1.77 3.90 0.0 6.0 312
No morbidity 3.55 1.65 3.90 0.0 6.0 323
Lubrication domain b 0.604
SMM 4.03 1.97 4.50 0.0 6.0 310
No morbidity 4.14 1.88 4.50 0.0 6.0 318
Orgasm domain a 0.999
SMM 3.78 2.01 4.40 0.0 6.0 312
No morbidity 3.87 1.86 4.40 0.0 6.0 323
Satisfaction domain c 0.635
SMM 4.43 1.53 4.80 0.8 6.0 287
No morbidity 4.42 1.47 4.80 0.8 6.0 305
Pain domain a 0.115
SMM 4.00 2.10 4.60 0.0 6.0 312
No morbidity 4.32 1.93 4.80 0.0 6.0 323
Total FSFI Score d 0.937
SMM 24.39 8.02 26.80 1.8 35.7 282
PLTC 24.79 7.87 26.90 1.8 35.7 223
MNM 22.87 8.47 24.10 2.0 34.5 59
No morbidity 24.42 7.80 26.50 2.0 36.0 301
* Nonparametric test: Mann-Whitney
Missing information for a: 3; b: 10; c: 46; d: 55 cases
doi:10.1371/journal.pone.0143581.t002
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Table 3. Mean values of FSFI scores according to maternal morbidity by somematernal and delivery characteristics. Values in bold mean that they
are statistically significant (p<0.05).
Characteristics Morbidity Mean SD n p-value *
Maternal age (y) a
 19 SMM 23.67 9.23 9 0.375
No morbidity 27.53 3.45 18
20–29 SMM 25.27 7.68 102 0.280
No morbidity 24.26 7.94 141
30–39 SMM 23.94 7.99 131 0.575
No morbidity 24.41 7.96 116
 40 SMM 23.79 8.78 40 0.637
No morbidity 23.24 8.35 26
Number of pregnancies a
1 SMM 25.05 7.75 91 0.862
No morbidity 24.79 7.88 102
 2 SMM 24.08 8.15 191 0.998
No morbidity 24.23 7.78 199
Schooling (years) b
Up to 8 SMM 23.41 7.90 93 0.789
No morbidity 23.69 7.69 83
Above 8 SMM 24.87 8.06 189 0.648
No morbidity 24.66 7.87 216
Ethnicity a
White SMM 24.31 7.99 133 0.427
No morbidity 24.77 8.20 122
Nonwhite SMM 24.47 8.08 149 0.430
No morbidity 24.19 7.54 179
Marital status c
With a partner SMM 24.88 7.54 247 0.922
No morbidity 25.25 6.53 261
Without a partner SMM 20.70 10.34 34 0.970
No morbidity 19.04 12.23 40
Time since delivery (y)a
< 1 SMM 24.88 7.56 41 0.519
No morbidity 24.72 7.61 37
1–<2 SMM 24.66 7.80 89 0.533
No morbidity 24.13 7.73 117
2–<3 SMM 23.95 9.09 95 0.677
No morbidity 24.80 8.20 95
 3 SMM 25.07 6.82 57 0.678
No morbidity 24.19 7.56 52
Route of delivery b
Vaginal SMM 24.97 7.61 54 0.959
No morbidity 24.78 7.90 157
Cesarean section SMM 24.28 8.15 226 0.535
No morbidity 24.04 7.71 144
Child outcome d
Alive SMM 24.63 7.61 235 0.695
No morbidity 24.33 7.76 288
(Continued)
Sexual Function and Severe Maternal Morbidity
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SMM. Finally, time elapsed between delivery and study interviews were not correlated to FSFI
total mean scores at both exposed and control group.
Although the rates of FSFI scores<26.55 were not different within groups considering all
women or only those reporting sexual activity during the past 4 weeks, exposed women took
longer to resume sexual activity after index pregnancy (mean of 84 days for women with SMM
and 65 days for those without complications, p = 0.011). This delay was significant at 45 days
postpartum, but no longer at 90 days. Additionally, when the outcome of child survival was
taken into account, the mean time to resume sexual activity was higher for women with SMM
and an alive child, while this difference was not significant for those who had a neonatal death.
The main reasons mentioned for postponing sexual activity were lack of partnership, lack of
interest, fear of being hurt, tiredness, and fear of getting pregnant again. Although no signifi-
cant differences were detected in both groups regarding these reasons, the fear of being hurt
among women with SMM was almost the double of those given by women with uncomplicated
pregnancies (Table 4).
The mean time to resume sexual activity was not influenced at all by parity (a proxy of num-
ber of young children living together), time since delivery (when a recall bias could be possible),
and by breastfeeding status. Only the absence of a partner showed to be associated with a lon-
ger time (Table 5), although without differences in scores between groups. Finally, logistic
regression analyses showed no association between FSFI below cut-off values with any predic-
tor assessed.
Discussion
Our findings show that women in the severe maternal morbidity group were older, with higher
cesarean section rates, and had more previous pathological conditions than women in the con-
trol group. In addition, there were no differences at all in the total and each domain FSFI scores
between women who had severe maternal morbidity and those without maternal complica-
tions. However, women experiencing SMM took longer than those without complications to
resume sexual activity in the postpartum period, independently of the outcome of the child,
parity, breastfeeding status or time since delivery. Multiple logistic regression analysis revealed
no association of low scores of FSFI with any predictor. Some previous studies described corre-
lation of sexual dysfunction and maternal age, years of schooling, ethnicity and mode of deliv-
ery. However, these findings presented conflicting conclusions [16–19]. To the best of our
knowledge, no other previous study addressed sexual functioning using validated question-
naires among women with severe maternal morbidity.
Although sexual dysfunction is recognized to be a health disorder [20, 21], the screening
and diagnosis of this condition is not easy and is not a routine practice, especially in association
with childbirth. When compared with women who had had an uncomplicated birth, those who
underwent episodes of severe maternal morbidity delayed resumption of sexual activity.
Accordingly, time to resume sexual intercourse after index pregnancy was meanly 18 days
Table 3. (Continued)
Characteristics Morbidity Mean SD n p-value *
Neonatal death SMM 20.02 10.75 11 0.583
No morbidity 25.92 5.53 5
* Nonparametric test: Mann-Whitney
Missing information for a: 52 cases; b: 57; c: 56; d: 99 cases.
doi:10.1371/journal.pone.0143581.t003
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longer at the exposed women. Furthermore, differences between groups were significant at 45
days postpartum, which provides evaluation beyond classic postpartum period definition (up
to 42 days). Possible pregnancy or childbirth repercussions are usually examined only at that
time span, and knowledge on long-term burden is very limited. Even without obtaining signifi-
cant difference between groups at 90 days after childbirth, our findings show that SMM group
delayed to resume sexual activity beyond postpartum period, as was the case also for women
without a partner, what is quite understandable. This delay was not shown to be associated
with neonatal outcome as found by a previous study, although the current numbers are per-
haps too low for definitive conclusions on this regard [9]. In addition, having a partner, and
therefore being sexually active, and time of breastfeeding were not associated with FSFI total
scores.
Additionally, “fear of being hurt” was more frequently mentioned as a reason for delaying
resumption of sexual activity among exposed women (23.4% versus 15.2%). Although statisti-
cal analysis was not feasible, the finding may possibly imply correlation between maternal
Table 4. Proportion of women identified as having FSFI total score <26.55, time to resume sexual activity and reasons for delaying resumption of
sexual activity according to maternal morbidity. Values in bold mean that they are statistically significant (p<0.05).
Characteristics Group
SMM No SMM p-value
Total FSFI score a n (%) n (%)
Only sexually active women
< 26.55 109 (41.9) 128(46.2) 0.361*
 26.55 151 (58.1) 149 (53.8)
All women
< 26.55 131 (46.5) 152 (50.5) 0.372*
 26.55 151 (53.5) 149 (49.5)
Time to resume sexual activity (days) b
 45 147 (49.2) 184 (59.5) 0.013*
> 45 152 (50.8) 125 (40.5)
 90 252 (85.1) 276 (89.8) 0.072*
> 90 47 (14.9) 33 (10.2)
Mean time (± SD) b 83.69 (±103.85) 65.39 (±81.62) 0.011**
Mean time to resume sexual activity X Child outcome (days) c
Child alive (n = 547) 86.3 (±110.2) 66.3 (±83.3) 0.019**
Neonatal death (n = 18) 73.3 (±61.1) 44.7 (±15.4) 0.437**
Total 315 323
Reasons for delaying resumption of sexual activity beyond 90 days #
No partner 20 (42.6) 16 (48.5)
Lack of interest 13 (27.7) 8 (24.2)
Fear of being hurt 11 (23.4) 5 (15.2)
Tiredness 2 (4.3) 2 (6.1)




# Test not applicable.
Missing information for a: 55; b: 30; c: 73 cases.
doi:10.1371/journal.pone.0143581.t004
Sexual Function and Severe Maternal Morbidity
PLOS ONE | DOI:10.1371/journal.pone.0143581 December 2, 2015 10 / 14
morbidity and longer or more intense soreness after delivery. Even more, specific SMM involv-
ing ICU admission or surgery recovery could lead to slower healing processes and more intense
pain perception, as well as emotional repercussions, which has been described related to termi-
nation of pregnancy [22].
On the other hand, we found no differences among groups regarding domains or total FSFI
scores. Although the Female Sexual Function Index questionnaire is widely applied as a sexual
function-screening tool, this evaluation is limited. The FSFI may not contain all possible emo-
tional and psychological elements needed to identify altered female sexual response. Despite
being validated to address subjectivity, the FSFI questionnaire assesses some biological aspects
of sexual response. Even the “arousal” component might be influenced by hormone levels,
which are notably lower during the postpartum period [23]. This particular component defined
the instrument´s construct validity [7]. In addition, there is high prevalence of suspected sexual
dysfunction in general female population, regardless age or any chronic disorders [16, 24–26].
Although several conditions were evaluated as exposure for sexual dysfunction in Brazil, spe-
cific cut-off values for the FSFI questionnaire had not yet been tested [24, 27–30]. As a result,
the originally established cut-off value for total FSFI scores is also applied in Brazilian studies,
as was the case also for the current one.
Nevertheless, the total FSFI scores among all women were lower than expected. In all
groups, total mean scores ranged from 22.87 to 24.79, when the cut-off value considered for
suspected sexual dysfunction was below 26.55 [31]. Mean and median FSFI scores also did not
differ among included women. However, median total score of 24.10 in the maternal near miss
sub-group was the only below the cut-off value 26.55. Despite not significant, this finding may
contribute to map possible long-term repercussions on these women´s lives.
Moreover, sexual satisfaction is acknowledged as a quality of life measurement parameter. A
previous study described 43% of prevalence of sexual problems among women after severe
maternal morbidity and its correlation with depressive symptoms. This prevalence is however,
the same described for the overall female population in USA. Overall, exposed women had
poorer general health condition [10, 16]. The impact of uncomplicated pregnancy and delivery
related to altered female sexual response has also been previously described [19, 32, 33]. There-
fore, it is reasonable to assume that severe obstetric morbidity might also contribute to modify
Table 5. Mean time to resume sexual activity according to some characteristics.
Characteristics Mean SD p-value
Parity 0.554
1 76,04 79,87
 2 73,59 99,62
Marital status <0.001
Without a partner 137,82 165,71
With a partner 63,60 69,65
Time since delivery (y) 0.540
< 1 74,89 73,99
1–<2 63,22 55,37
2–<3 79,13 106,66
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such aspects of women´s lives. Together with delay to resumption of sexual activity, suspected
sexual dysfunction on women who experienced MNMmight suggest correlation between these
conditions and altered self-perception regarding quality of life. Additionally, despite being
high, maternal death ratio has been dropping for several years. Consequently, there is a grow-
ing population of SMM and MNM surviving women who were so far not properly evaluated.
The current study has of course some possible limitations. Although this was a cohort
study, evaluation of outcomes might be limited because of the retrospective way the data were
collected. Ideally in a prospective follow-up, the women should be followed and information
regarding sexual activity and function should be collected at predetermined regular periods
after delivery. In this study, information on sexual aspects was collected just once in different
times of postpartum period, however no differences at all were found in relation to the time
since delivery, suggesting a lower likelihood of an important recall bias effect. This was a multi-
dimensional study, and was not specifically addressed to evaluate completely the female sexual
response. Therefore, some relevant variables of sexual life were not included, such as informa-
tion on lactational amenorrhea, social support for breastfeeding or family contexts. Thus, a
prospective evaluation is proposed for the next research step approaching this topic. Further-
more, there are not specific standardized cut-off values for the FSFI score to be applied among
Brazilian women and, in addition, after severe maternal morbidity this has never been per-
formed before.
Our study showed that women who experienced episodes of severe maternal morbidity
delayed resumption of sexual activity, although FSFI did not differ between groups. FSFI scores
had not been compared before among women with or without severe morbidity. The absence
of statistically significant differences between exposed and not exposed groups might be corre-
lated to high prevalence of altered FSFI scores, perhaps due to questionnaire´s limitations. Nev-
ertheless, all FSFI mean total scores were below the cut-off value. Moreover, sexual
dysfunction, as well as a broader evaluation of sexual life aspects should be further and in-
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